The Myth of Americans' Poor Life Expectancy - Forbes

Link: http://www.forbes.com/sites/theapothecary/2011/11/23/the-myth-of-americans-poor-life-expectancy/ (via shareaholic.com)

Life expectancy is an appealingly simplistic, but deeply flawed, way to think about the quality of a country's health-care system. After all, shouldn't good health care make you live longer? Well, yes, but. The problem, of course, is that there are many factors that affect life expectancy.
One is wealth. It's gross domestic product per capita, and not health-care policy, that correlates most strongly to life expectancy. Gapminder has produced many colorful charts that show the strong correlation between wealth and health. Here's one from Lane Kenworthy of the University of Arizona:

If you really want to measure health outcomes, the best way to do it is at the point of medical intervention. If you have a heart attack, how long do you live in the U.S. vs. another country? If you're diagnosed with breast cancer? In 2008, a group of investigators conducted a worldwide study of cancer survival rates, called CONCORD. They looked at 5-year survival rates for breast cancer, colon and rectal cancer, and prostate cancer. I compiled their data for the U.S., Canada, Australia, Japan, and western Europe. Guess who came out number one?

A few years back, Robert Ohsfeldt of Texas A&M and John Schneider of the University of Iowa asked the obvious question: what happens if you remove deaths from fatal injuries from the life expectancy tables? Among the 29 members of the OECD, the U.S. vaults from 19th place to…you guessed it…first. Japan, on the same adjustment, drops from first to ninth.

Finally, U.S. life-expectancy statistics are skewed by the fact that the U.S. doesn't have one health-care system, but three: Medicaid, Medicare, and private insurance. (A fourth, the Obamacare exchanges, is supposed to go into effect in 2014.) As I have noted in the past, health outcomes for those on government-sponsored insurance are worse than for those on private insurance.

For further reading on the topic of life expectancy, here are some recommendations. Harvard economist Greg Mankiw discusses some of the confounding factors with life expectancy statistics, citing this NBER study by June and Dave O'Neill comparing the U.S. and Canada. (Mankiw calls the misuse of U.S. life expectancy stats "schlocky.") Chicago economist Gary Becker makes note of the CONCORD study in this blog post. In 2009, Sam Preston and Jessica Ho of the University of Pennsylvania published a lengthy analysis of life expectancy statistics, concluding that "the low longevity ranking of the United States is not likely to be a result of a poorly functioning health care system."